The government says more than 2.5 million people have signed up since President Biden ordered the HealthCare.gov marketplace to reopen Feb. 15 to account for health insurance needs in the pandemic.
The administration is encouraging businesses to follow its lead on incentivizing vaccinations by imposing burdens on the unvaccinated.
Federal legal guidance suggests the law is on the side of employers who want to mandate COVID-19 shots. But what happens if workers refuse?
Employees will have eight weeks to get vaccinated.
In a federal investigation in a hard-hit Colorado location, disease detectives found many workers were not inoculated.
The report from the inspector general of the Department of Health and Human Services found that about 4 in 10 Medicare recipients in nursing homes had or likely had COVID-19 in 2020.
The solid start to the three-month special enrollment period indicates a pent-up demand for health insurance as the COVID-19 pandemic approaches the one-year mark and many people remain unemployed or unable to work as many hours as they did before the outbreak.
The Pentagon will deploy more than 1,100 troops to five vaccination centers in what will be the first wave of increased military support for vaccinations.
Coronavirus coordinator Jeff Zients said starting next week some 6,500 pharmacies around the country will receive a total of 1 million doses of vaccine.
The directive is a down payment on the president’s pledge to make health care more accessible and affordable.
A federal mask order for travel will apply to airports and planes, ships, intercity buses, trains and public transportation.
Under the Trump administration’s approach, the government has been holding back millions of doses to guarantee that people can get a second shot, which provides maximum protection against COVID-19.
Under a deal with the federal government announced Wednesday, the company will deliver at least 70 million of the additional vaccine doses by June 30, with the remaining 30 million to be delivered no later than July 31.
It’s hard to say whether the new rules will withstand expected legal challenges from the pharmaceutical industry or whether the incoming Biden administration will accept, amend or try to roll them back entirely.
A multistate coronavirus surge in the countdown to Election Day has exposed a clear split between President Trump’s bullish embrace of a return to normalcy and urgent public warnings from top health officials.